Vulnerability index impacts distribution of prostate cancer clinical trials in the United States
Background Availability of clinical trials for prostate cancer in the US varies greatly by region. County-level analyses are vital to characterize healthcare access, disease burden, and population-level disparities. Methods Utilizing the ClinicalTrials.gov trial database, we collated all interventional prostate cancer...